Hepion Pharmaceuticals (HEPA) announced that it will implement a 1-for-50 reverse split of the issued shares of its common stock, effective on March 17, 2025. The Company’s common stock is ...

Eton Pharmaceuticals (ETON) announced positive results from its bioequivalence study of ET-600, a proprietary, patented oral solution of desmopressin under development for the treatment of central ...

The 21st century pharmaceutical and biotech sector has ... the benefit of human health was a comparatively late development. Merck in Germany was possibly the earliest company to move in this ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

IPC Indice de Precios Y Cotizaciones 51,877.12-163.89-0.31% ...